Transplant monitoring kits sales will strengthen through 2036, anchored by reagents and consumables at 57% of the product segment in 2026. The market was valued at USD 5.69 billion in 2025 and is expected to be worth USD 9.14 billion by 2036, creating an incremental opportunity of USD 3.20 billion.